PP

Pravin Purud

Active Director Director DIN 09231157
DIN 09231157 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Pravin Purud

Data last updated:

Pravin Purud is a Director at Bakale Medical Private Limited (since 2021). The company operates in Pharma. Bakale Medical Private Limited reported revenue of ₹2.09 Cr (FY 2025).

DIN 09231157
Primary Designation Director
Industry Pharma
First Appointment 12 Jul 2021
Oldest Company Age 5 yrs
Largest company Bakale Medical Private Limited · ₹2.09 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bakale Medical Private Limited U85100PN2021PTC201062
Director12 Jul 20212021₹2.09 Cr (FY 2025)Active

Board colleagues of Pravin Purud

Directorship timeline

Open interactive timeline →
Bakale Medical Private Limited
Premium access

Shareholding and investment profile for Pravin Purud

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravin Purud

Pravin Purud currently holds 1 directorship: Bakale Medical Private Limited (Director, since 12 Jul 2021, revenue ₹2.09 Cr (FY 2025)).

Pravin Purud was first appointed on 12 Jul 2021 as Director at Bakale Medical Private Limited.

The current boards of Pravin Purud's companies include Rohit Govind Bakale (Bakale Medical Private Limited), Shweta Rohit Bakale (Bakale Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available